Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Injection vs Victoza in Metformin-treated Type 2 Diabetes (China, Phase III)
CTR20201453Phase 3Completed
- Sponsor
- Wanbang Biopharmaceuticals
- Start
- Jul 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Wanbang Biopharmaceuticals. Started Jul 2020; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20201453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201453.